当前位置: 首页 > 期刊 > 《中国现代医生》 > 2011年第35期 > 正文
编号:12144447
急诊重症监护室鲍曼不动杆菌感染分析及防治(1)
http://www.100md.com 2011年12月15日 陈美娟 吕火祥 张美齐
第1页

    参见附件(3055KB,3页)。

     [摘要] 目的 分析急诊重症监护室(EICU)鲍曼不动杆菌(Acinetobacter baumanii,AB)感染的分布特点及耐药情况,为预防和治疗AB感染提供依据。方法 回顾性分析了2009年10月~2011年1月EICU采集的98株AB标本的分布与耐药情况。 结果 98株AB标本,主要为痰液来源,为80株,占81.6%。药敏试验显示AB对头孢他啶、哌拉西林/他唑巴坦的耐药率均超过60%;对环丙沙星、左氧氟沙星、氨曲南、复方新诺明、庆大霉素的耐药率分别为73.6%、60.2%、79.3%、70.3%、68.3%;对亚胺培南、美洛培南分别为49.5%、50.6%。米诺环素及头孢哌酮/舒巴坦、多黏菌素B的耐药率较低,分别为21.3%、35.6%、6.8%。结论 为有效控制AB引起的院内感染,可先经验性地选用头孢哌酮/舒巴坦或碳青霉稀类,后及时根据药敏结果调整用药方案。严格消毒隔离措施,增强患者的机体免疫力也十分重要。

    [关键词] 鲍曼不动杆菌;感染;抗菌药物;耐药性

    [中图分类号] R446 [文献标识码] B [文章编号] 1673-9701(2011)35-66-02

    Analyzing and Controlling the Acinetobacter Baumannii Infection in Emergency Intensive Care Unit

    CHEN Meijuan1 LV Huoxiang2 ZHANG Meiqi3

    1.Department of Infectious Diseases,Zhejiang Province People’s Hospital of Hangzhou City,Hangzhou 310014,China;2. Department of Laboratory, Zhejiang Province People’s Hospital of Hangzhou City,Hangzhou 310014,China;3. Emergency Intensive Care Unit,Zhejiang Province People’s Hospital of Hangzhou City,Hangzhou 310014,China

    [Abstract] Objective To investigate the distribution characteristics and drug resistance of Acinetobacter baumanii infection in Intensive Care Unite(EICU),and to offer reference for clinical control of nosocomial infection caused by A.baumanii. Methods The clinical disitribution and drug resistance of 98 strains of A.baumanii in EICU were retrospectively analyzed from Oct. 2009 to Jan.2011. Results Among 98 A.baumanii specimens,the dominant specimen was the sputum,which had 80 strains,taking up 81.6%.the results of antibiotic susceptibility tests showed that for most antimiembials,the drug resistance rates were high,which exceed 60%.For imipenem and Meropenem,the drug resistance rates were 49.5% and 50.6% respectively. While for Minocycline,cefopera-zone and Colistin B,their drug resistance rates were relatively lower,which taking up 21.3%,35.6% and 6.8% respectively. Conclusion Cefopera-zone/sulbactam and carbapenems can be selected to treat A ......

您现在查看是摘要介绍页,详见PDF附件(3055KB,3页)